Calavo Sinks 16% As 1Q Sales Outlook Lags Street Estimates

Shares of Calavo Growers plunged 16% in Monday’s extended trading after the fresh food provider posted lower-than-expected revenues and earnings in the fourth quarter. Additionally, the company’s 1Q revenue outlook also fell short of analysts’ estimates.

Don't Miss Our Christmas Offers:

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter

Calavo’s (CVGW) 4Q earnings of $0.34 per share declined 24.4% year-over-year, and missed the Street’s estimates of $0.64 per share. Revenue dropped 20% to $234.4 million year-over-year and lagged the consensus estimates of $256.1 million.

The company’s CEO James E. Gibson said, “Avocado volumes increased due to rising popularity in the U.S. and abroad.” He added, “Our fourth quarter results reflect a continuation of trends from the third quarter. With strong crops out of both Mexico and California, supply in the fourth quarter was plentiful, lowering the average selling price by 22% versus the year-ago quarter, when supply was very constrained. Many foodservice outlets remained unavailable to absorb the crop size and quality dispersion, which has historically helped to maintain margins. As a result, revenue and gross margin declined year-over-year.” (See CVGW stock analysis on TipRanks)

As for 1Q, Calavo expects to generate revenue in the range of $215 million to $225 million, compared to analysts’ projections of $257.8 million.

On Dec. 11, Jefferies analyst Robert Dickerson maintained a Hold rating and a price target of $73 (1% upside potential) on the stock. The analyst said that, “While we like the synergistic cost strategy, in-house RFG [Renaissance Food Group] manufacturing, branded innovation, and clean B/S [balance sheet], we’re waiting for improved visibility around pricing recovery potential before becoming more constructive.”

Currently, the Street has a cautiously optimistic outlook on the stock with a Moderate Buy analyst consensus. The average price target stands at $79 and implies upside potential of about 9.3% to current levels. Shares have fallen by 20.2% year-to-date.